The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.
Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1
Open accessAbstract
This study examines endothelin-induced modulation of extracellular matrix synthesis and remodeling by fibroblasts, and its potential role in the pathogenesis of systemic sclerosis (scleroderma). Endothelin-1 promoted fibroblast synthesis of collagen types I and III, but not fibronectin, by a mechanism dependent upon both ETA and ETB receptors. Conversely, endothelin-1 inhibited both protein expression of matrix metalloproteinase 1 and zymographic activity exclusively via ETA receptors. A dual regulatory role for endothelin-1 in transcriptional regulation was suggested by the ability of endothelin-1 to enhance steady-state levels of collagen mRNA and activate the proalpha2(I) collagen (Col1a2) promoter, but in contrast to reduce matrix metalloproteinase 1 transcript expression and suppress transcription of a human matrix metalloproteinase 1 promoter reporter construct in transient transfection assays. Although endothelin-1 significantly enhanced remodeling of three-dimensional collagen lattices populated by normal fibroblasts, this was not observed for lattices populated by systemic sclerosis fibroblasts. Promotion of matrix remodeling was dependent upon ETA receptor expression and was blocked by specific inhibitors of tyrosine kinases or protein kinase C. Reverse transcriptase polymerase chain reaction, S1 nuclease, and functional cell surface binding studies showed that normal and systemic sclerosis fibroblasts express both ETA and ETB receptors (predominantly ETA), but that ETA receptor mRNA levels and ETA binding sites on fibroblasts cultured from systemic sclerosis skin biopsies are reduced by almost 50%. Endothelin-1 is thus able to induce a fibrogenic phenotype in normal fibroblasts that is similar to that of lesional systemic sclerosis fibroblasts. Moreover, reduced responsiveness to exogenous endothelin-1 in systemic sclerosis suggests that downstream pathways may have already been activated in vivo. These data further implicate dysregulated endothelin-receptor pathways in fibroblasts in the pathogenesis of connective tissue fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
From A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression (2017) · cites this paper as Shi-Wen et al., 2001
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,925
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,645
Fibroblasts, myofibroblasts, and wound contraction
Grinnell, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.401 · Cited by 1,141
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711
LeRoy, E. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107827 · Cited by 543
Hocher, B., Thöne‐Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V. R., Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H.-H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 411
Langholz, O., Roeckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., & Eckes, B. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1903 · Cited by 397
Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356
Effects of endothelins on collagen turnover in cardiac fibroblasts
Eduardo Guarda, S., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291
Cited by
Sorted by citations
Items 201–243 of 243
Reactive Oxygen Species and Scleroderma
Yamamoto, T. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_105 · Cited by 1
Drug Repurposing Patent Applications July–September 2019
Mucke, H. A. (2020) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.969 · Cited by 1
Motegi, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-55708-1_10 · Cited by 1
Pulmonary Arterial Hypertension in Connective Tissue Disease
Denton, C. P., & Black, C. M. (2004) · Technical report · doi:10.1016/s1571-5078(04)02003-3 · Cited by 1
Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.
Pankey, E. A., Epps, M., Nossaman, B. D., Hyman, A. L., & Kadowitz, P. J. (2010) · PubMed · Cited by 1
Downregulation of the Endothelin System of Lung Myofibroblasts in Congestive Heart Failure
Préfontaine, A., Calderone, A., & Dupuis, J. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181ad7d57 · Cited by 1
Blocage de l'endothéline dans la sclérodermie systémique : rationnel et bénéfice clinique
Denton, C. P., & Black, C. M. (2007) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(07)80019-1 · Cited by 1
Martin, P. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-07122012-154623
Endothelin-1 and Systemic Sclerosis
Pearson, J. D., Shiwen, X., Howat, S., Denton, C. P., & Abraham, D. (2009) · Springer eBooks · doi:10.1007/978-1-84882-637-3_6
Vascular Complications of Systemic Sclerosis: A Molecular Perspective
Baker, D., & Denton, C. P. (2008) · Springer eBooks · doi:10.1007/978-1-84628-919-4_9
TAK1 Mediates TGF beta-1 Responses in Gingival Fibroblasts
Kuk, H. (2014) · Scholarship@Western (Western University)
Bosentan dans la sclérodermie: Perspectives
BEREZNE, A., Mouthon, L., & Guillevin, L. (2007) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(07)80025-7
Dashwood, M. R., & Tsui, J. C. S. (2002) · Angiology · doi:10.1177/000331970205300620
Current brain endothelin research: a pathway to novel approaches impacting clinical trials
Rafols, J. A., & Kreipke, C. W. (2011) · Neurological Research · doi:10.1179/016164111x12881719352057
Complex Raynaud’s phenomenon: evolving concepts of management
Meier, F. M., Frerix, M., & Müller‐Ladner, U. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.65
Chung, L. S., Distler, O., Hummers, L. K., Krishnan, E., & Steen, V. D. (2011) · International Journal of Rheumatology · doi:10.1155/2011/308231
Advances in disease-specific treatment of systemic sclerosis
Shenin, M., Naik, M., & Derk, C. T. (2009) · International Journal of Clinical Rheumatology · doi:10.2217/17584272.4.1.67
Vascular Endothelin and Angiotensin Receptors Regulation in Inflammatory Arterial Disorders
Dimitrijević, I. (2010) · Lund University Publications (Lund University)
Updates on the pathophysiology of dermal sclerosis
Yamamoto, T. (2012) · Expert Review of Dermatology · doi:10.1586/edm.12.57
Fibrosis pulmonar idiopática. Nuevas terapéuticas y evidencia científica
Espinosa, Á. C., & Ancochea, J. (2007)
[Pharmacological characteristics and clinical efficacy of bosentan].
Fujimoto, K., & Ikenoya, S. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.126.407
Pulmoner arteriyel hipertansiyon: patogenez
Öztürk, Ö., & Akkaya, A. (2009) · DergiPark (Istanbul University) · doi:10.17343/sdutfd.68815
The Pathogenesis of Intraabdominal Adhesions: Similarities and Differences to Luminal Fibrosis
Macarak, E. J., & Rosenbloom, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_22
Traitement de la fibrose pulmonaire idiopathique
Valeyre, D., & Dion, G. (2010) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32328-3 · Cited by 1
Müller‐Ladner, U. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00094-9
Genetic polymorphisms in systemic sclerosis
Gutierrez, F., & del Carmén, M. (2003) · UCL Discovery (University College London)
NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION
Маrtynuk, T. V., Наконечников, С. Н., & Chazova, I. E. (2013) · Eurasian heart journal · doi:10.38109/2225-1685-2013-1-6-17
Derk, C. T., & Jiménez, S. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_100
(2004) · Springer eBooks · doi:10.1007/3-540-29662-x_1048
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis – An Update
Spagnolo, P., Nunès, H., & Wuyts, W. A. (2013) · EMJ Respiratory · doi:10.33590/emjrespir/10314639
Kocken, J. M. M. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240516jk
Role of regulatory T cells in pathogenesis and therapeutics of scleroderma (systemic sclerosis)
Dar, S. A., Das, S., Jawed, A., Nasreen, N., & Rai, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13947-5.00010-5
Decoding the microRNA Landscape in Systemic Sclerosis: Insights from in Silico Predictions
Singh, H., Chaturvedi, S., Udumula, M. P., Bhatnagar, A. R., & Rawat, A. K. (2024) · Indian Journal of Rheumatology · doi:10.1177/09733698241271473
Antiproliferative therapies in pulmonary arterial hypertension
Zolty, R. L. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2601059
Papel del eje TGF- -endotelina 1 en la fi brosis: lecciones del endotelio y el fi broblasto
Lagares, D., Rodríguez‐Pascual, F., & Lamas, S. (2010) · Gastroenterología y Hepatología
Vascular dysfunction in renal injury and cognitive dysfunction: the central role of endothelin-1
McCrorey, M. K., Palygina, L., Butler, H. M., & Beusecum, J. P. V. (2026) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2026-0030
Early to midgestational testosterone excess leads to adverse lung programming in sheep offspring
Razan, M. R., Woo, K. V., Purswani, D., Bernal, D., Alkhatib, B., Li, T., Padmanabhan, V., & Vyas, A. K. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00034.2026
Metadata
- Authors
- Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D.
- Affiliations
- The Royal Free Hospital (GB)
- King's College London (GB)
- Corresponding author
- Abraham, David J.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 116
- Issue
- 3
- Pages
- 417-425
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2064485592
- Cited by
- 243
- References
- 35
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- endothelin-1, systemic sclerosis, fibroblasts, extracellular matrix remodeling, collagen synthesis, type I collagen, type III collagen, fibronectin, MMP-1, ETA receptor, endothelin B receptor, connective tissue fibrosis, tyrosine kinase inhibitors, protein kinase C
- MeSH terms
- Cells, Cultured, Collagen, Connective Tissue, Extracellular Matrix, Fibroblasts, Humans, Reference Values, RNA, Messenger, Scleroderma, Systemic, Transcription, Genetic, Gene Expression, Receptors, Endothelin, Endothelin-1, Matrix Metalloproteinase 1, Receptor, Endothelin A, Receptor, Endothelin B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review